Keller ET - Search Results

1

A bioluminescent orthotopic mouse model of human osteosarcoma that allows sensitive and rapid evaluation of new therapeutic agents In vivo.

Comstock KE, Hall CL, Daignault S, Mandlebaum SA, Yu C, Keller ET. Comstock KE, et al. Among authors: keller et. In Vivo. 2009 Sep-Oct;23(5):661-8. In Vivo. 2009. PMID: 19779098 Free article.

2

Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice.

Smith PC, Keller ET. Smith PC, et al. Among authors: keller et. Prostate. 2001 Jun 15;48(1):47-53. doi: 10.1002/pros.1080. Prostate. 2001. PMID: 11391686 Free article.

3

Bone turnover mediates preferential localization of prostate cancer in the skeleton.

Schneider A, Kalikin LM, Mattos AC, Keller ET, Allen MJ, Pienta KJ, McCauley LK. Schneider A, et al. Among authors: keller et. Endocrinology. 2005 Apr;146(4):1727-36. doi: 10.1210/en.2004-1211. Epub 2005 Jan 6. Endocrinology. 2005. PMID: 15637291

4

Prostate cancer cells promote osteoblastic bone metastases through Wnts.

Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET. Hall CL, et al. Among authors: keller et. Cancer Res. 2005 Sep 1;65(17):7554-60. doi: 10.1158/0008-5472.CAN-05-1317. Cancer Res. 2005. PMID: 16140917

5

Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.

Kitagawa Y, Dai J, Zhang J, Keller JM, Nor J, Yao Z, Keller ET. Kitagawa Y, et al. Among authors: keller et, keller jm. Cancer Res. 2005 Dec 1;65(23):10921-9. doi: 10.1158/0008-5472.CAN-05-1809. Cancer Res. 2005. PMID: 16322239

6

Role of Wnts in prostate cancer bone metastases.

Hall CL, Kang S, MacDougald OA, Keller ET. Hall CL, et al. Among authors: keller et. J Cell Biochem. 2006 Mar 1;97(4):661-72. doi: 10.1002/jcb.20735. J Cell Biochem. 2006. PMID: 16447163 Free article. Review.

7

Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice.

Wallner L, Dai J, Escara-Wilke J, Zhang J, Yao Z, Lu Y, Trikha M, Nemeth JA, Zaki MH, Keller ET. Wallner L, et al. Among authors: keller et. Cancer Res. 2006 Mar 15;66(6):3087-95. doi: 10.1158/0008-5472.CAN-05-3447. Cancer Res. 2006. PMID: 16540658

8

Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.

Hall CL, Dai J, van Golen KL, Keller ET, Long MW. Hall CL, et al. Among authors: keller et. Cancer Res. 2006 Sep 1;66(17):8648-54. doi: 10.1158/0008-5472.CAN-06-1544. Cancer Res. 2006. PMID: 16951179

9

The role of Wnts in bone metastases.

Hall CL, Keller ET. Hall CL, et al. Among authors: keller et. Cancer Metastasis Rev. 2006 Dec;25(4):551-8. doi: 10.1007/s10555-006-9022-2. Cancer Metastasis Rev. 2006. PMID: 17160558 Review.

10

New trends in the treatment of bone metastasis.

Keller ET, Dai J, Escara-Wilke J, Hall CL, Ignatoski K, Taichman RS, Keller J. Keller ET, et al. Among authors: keller j. J Cell Biochem. 2007 Dec 1;102(5):1095-102. doi: 10.1002/jcb.21540. J Cell Biochem. 2007. PMID: 17955492 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page